METiS Therapeutics is based in Beijing, China. It has raised $252M in total funding. Latest round: Series A.
METiS Therapeutics is based in Beijing, China. METiS Therapeutics has raised $252M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in January 2021. The round record for METiS Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include PICC PE, China Life, Sequoia Capital China, Lightspeed, 5Y Capital, Frees Fund Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
Round data for METiS Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Beijing and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026